Concepedia

Peter Bossuyt

PB

Statistics

Publications

2

Citations

165

H-Index

2

Active since

2021

Affiliations

Inserm(Current)

Peter Bossuyt is an author at Inserm specializing in gastroenterology, immunology, and medicine.

Top concepts

Publications per year

2021–2024

2

Publications

2

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

, , +7

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

, , +5

1–2 of 2